Circulating anti-p16a IgG autoantibodies as a potential prognostic biomarker for non-small cell lung cancer

Study of Novel Autoantibodies in Schizophrenia

(2018) Ruth Whelan et al.   SCHIZOPHRENIA BULLETIN

Plasma anti-BIRC5 IgG may be a useful marker for evaluating the prognosis of nonsmall cell lung cancer

(2018) Huan Zhao et al.   FEBS Open Bio

A hybrid solution for extracting structured medical information from unstructured data in medical records via a double-reading/entry system

(2016) Ligang Luo et al.   BMC Medical Informatics and Decision Making

A study of type-1 diabetes associated autoantibodies in schizophrenia

(2016) Philomena Hallford et al.   SCHIZOPHRENIA RESEARCH

Anti-p16 autoantibodies may be a useful biomarker for early diagnosis of esophageal cancer

(2014) Yonglong Jin et al.   Asia-Pacific Journal of Clinical Oncology

Detection of autoantibodies to multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer

(2014) Weihong Liu et al.   TUMOR BIOLOGY

The Molecular Balancing Act of p16 INK4a in Cancer and Aging

(2013) Kyle M. LaPak et al.   MOLECULAR CANCER RESEARCH

Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer

(2013) Cong Zhang et al.   TUMOR BIOLOGY

Expression of p16 in non-small cell lung cancer and its prognostic significance: A meta-analysis of published literatures

(2011) Jinlong Tong et al.   LUNG CANCER

p16Ink4a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors

(2011) C Romagosa et al.   ONCOGENE

Cell Proliferation, Cell Cycle Abnormalities, and Cancer Outcome in Patients with Barrett's Esophagus: A Long-term Prospective Study

(2008) D. L. Chao et al.   CLINICAL CANCER RESEARCH

Molecular analysis of the Ink4a/Rb1–Arf/Tp53 pathways in radon-induced rat lung tumors

(2008) Kristell Bastide et al.   LUNG CANCER